Delivery Order SPE2DB22D1202-SPE2DB24FUHM6

Award Date 11/21/23
Potential Completion Date 11/22/23
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,035.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4564675659 ! ATOMOXETINE HCL 40 MG CAPSULE 30S, a prescription medication. This is a Firm Fixed Price Delivery Order contract with a completion date of May 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,391.63, is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, with a potential value of $1,264.71 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp, operating out of its Corporate Office division in...
This federal contract award, valued at $1,720.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4560748911 ATOMOXETINE HCL 60 MG CAPSULE 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the Ultimate Completion Date is April 28, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
This is a $1,766.35 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4562876774 ATOMOXETINE HCL 40 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of November 22, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,432.16 firm fixed-price delivery order is for the supply of 4556432935 ATOMOXETINE HCL 40 MG CAPSULE 30S. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,242.67 firm-fixed-price delivery order is for the supply of ATOMOXETINE HCL 10 MG CAPSULES, with a completion date of November 8, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order (SPE2DX24F1VUX) for the supply of 4565573039 - ATOMOXETINE HCL 10 MG CAPSULE 30S. The $1,090.47 firm fixed price contract has an ultimate completion date of August 27, 2024 and was awarded on August 26, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical. This contract is not set aside for any specific business type. As a large distributor of pharmaceutical products...
The U.S. Department of Defense's (DoD) Defense Logistics Agency (DLA) Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of pharmaceutical products, including the supply of 4565140856 ATOMOXETINE HCL 40 MG CAPSULE 30S. The contract, with a ceiling value of $3,577.19, has an ultimate completion date of July 16, 2024 and was awarded on July 15, 2024. This order is part of a larger Indefinite...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,723.67 award is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, a pharmaceutical product, with a completion date of February 12, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FUHM6
    Delivery Order

This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,000.45, is a Delivery Order for the supply of 4562879322 ! ATOMOXETINE HCL 60 MG CAPSULE 30S. The contract has a period of performance through November 22, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is a for-profit corporate entity that specializes in distributing a wide range of pharmaceutical products and medical supplies to federal government agencies, particularly within military and veterans' healthcare systems. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/12/25, 10:12 AM